Ferma empowers researchers, developers, and industry leaders to unlock eureka moments that
reshape the future of life sciences through a trio of AI-powered tools.
What do you get when you combine ChatGPT generative AI technology with specific pharma and clinical datasets? A time-saving tool that can answer questions about medical conference abstracts and clinical findings in seconds in one new application from ZoomRx called FermaGPT.
As excitement around ChatGPT and other generative AI programs grows, one company, ZoomRx, has launched its own tool to help transform how pharma analyzes data coming out of medical congresses.
The most talked about technology of the current moment for those in the life sciences—or any industry really—is artificial intelligence (AI). It was certainly top of mind for our readers when they responded to our questions about technology. You can find more of their responses on pages 36 through 38, but here are six areas where they see AI making a significant impact in the life sciences.
In the ever-evolving landscape of life sciences, efficient and accurate communication between HCPs and pharmaceutical companies is paramount. Among the many critical processes in this domain, managing medical inquiries stands out as the bridge that connects providers with pharma, offering an essential exchange of information about therapies, programs, and clinical trials.
Meta is looking to differentiate itself as a “safe” social media platform, but insiders say more ads made by pharma companies including Sanofi and Gilead have been ensnared by the social media giant’s enforcement policies.
Michael Terpstra
VP Commercial Strategy & Competitive Intelligence at Affimed
Alex Sun
Manager, Portfolio Strategy and Business Insights at CStone Pharmaceuticals
Chris Linzer
Senior Director, CI, BMS
